FibreTuff PAPC Material Displays High Level of Radiopacity in Recent Tests

FibreTuffSpine

FibreTuff Medical Biopolymers, a biomaterials compounding company, announced that a spinal implant made with its PAPC additively-manufactured filament displayed a high level of radiopacity in a CT scan during clinical testing.

PAPC (polyamide polyolefin and cellulose) material can be used for 3D printing and molding of Class I and II devices for spine, trauma and arthroscopy/soft tissue applications; namely bone screws, plates, spinal cages, spacers, anchors and staples.

According to FibreTuff, PAPC filament can be used in 3D printers without the odors traditionally associated with the printing process. PAPC is currently used to make bone replacements, mesh and temporary implants.

In 2Q18, FibreTuff received notification from NAMSA that testing of PAPC passed USP Class VI certification for temporary implants. In 3Q18, the company opened a new production facility in West Unity, Ohio.

The company is seeking an OEM partner for the manufacture of Class III devices, according to founder Robert Joyce.

Source: FibreTuff

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE